+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Prodrug"

From
API CDMO Market Size, Share, and Trends - Forecast to 2036 - Product Thumbnail Image

API CDMO Market Size, Share, and Trends - Forecast to 2036

  • Report
  • October 2026
  • 288 Pages
  • Global
From
Peptide Therapeutics Market - Global Forecast to 2036 - Product Thumbnail Image

Peptide Therapeutics Market - Global Forecast to 2036

  • Report
  • September 2026
  • 310 Pages
  • Global
From
From
Disposable Flow-Battery Bioreactor Market Report 2026 - Product Thumbnail Image

Disposable Flow-Battery Bioreactor Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
Cancer Monoclonal Antibodies Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Monoclonal Antibodies Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 186 Pages
  • Global
From
Biopharmaceutical CMO & CRO Market - Global Forecast 2026-2032 - Product Thumbnail Image

Biopharmaceutical CMO & CRO Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 190 Pages
  • Global
From
Biologics Contract Development Market - Global Forecast 2026-2032 - Product Thumbnail Image

Biologics Contract Development Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 184 Pages
  • Global
From
Loading Indicator

Prodrugs are a type of biotechnology that involves the modification of a drug molecule to improve its pharmacokinetic properties. This is done by making the drug more soluble, increasing its absorption, or making it more stable in the body. Prodrugs are designed to be more effective and safer than the original drug, and can be used to treat a variety of diseases. Prodrugs are used in a variety of therapeutic areas, including cancer, cardiovascular disease, and infectious diseases. They are also used to improve the delivery of drugs to specific tissues or organs, and to reduce the side effects of drugs. The prodrug market is growing rapidly, driven by the increasing demand for more effective and safer drugs. The market is expected to continue to grow in the coming years, as more companies develop and launch new prodrugs. Some companies in the prodrug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more